Evidence map›Paper›PMID 35931300›Full record

ArticleKidney international2022

Persistent DNA damage underlies tubular cell polyploidization and progression to chronic kidney disease in kidneys deficient in the DNA repair protein FAN1.

Merlin Airik, Yu Leng Phua, Amy B Huynh, Blake T McCourt, Brittney M Rush, Roderick J Tan, Jerry Vockley, Susan L Murray, Anthony Dorman, Peter J Conlon and 1 more

Open access · greenAbstract read
In one paragraph

Article in Kidney international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. TRIM21 inhibition alleviates acute kidney injury by promoting INTS3-associated DNA damage repair.Apoptosis : an international journal on programmed cell death · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Tubular Cell Polyploidy and AKI-to-CKD Transition.Journal of the American Society of Nephrology : JASN · 2025
    Article
  10. Article
  11. Article
  12. Genes · 2024
    Article
  13. Phenotypic and Genotypic Features of theInternational journal of molecular sciences · 2024
    Article
  14. Article
  15. Chronic kidney disease in children: an update.Clinical kidney journal · 2023
    Review
  16. Article
  17. Modeling ofCells · 2023
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Merlin AirikDivision of Nephrology, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Yu Leng PhuaDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Amy B HuynhDivision of Nephrology, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Blake T McCourtDivision of Nephrology, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Brittney M RushRenal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Roderick J TanRenal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Jerry VockleyDivision of Genetic and Genomic Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Susan L MurrayDepartment of Nephrology, Beaumont Hospital and Royal College of Surgeons in Ireland, Dublin, Ireland.
Anthony DormanDepartment of Nephrology, Beaumont Hospital and Royal College of Surgeons in Ireland, Dublin, Ireland.
Peter J ConlonDepartment of Nephrology, Beaumont Hospital and Royal College of Surgeons in Ireland, Dublin, Ireland.
Rannar AirikDivision of Nephrology, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA; Department of Developmental Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Electronic address: airikr@pitt.edu.
University of Pittsburgh · USChildren's Hospital of Pittsburgh · USRoyal College of Surgeons in Ireland · IEBeaumont Hospital · IEIcahn School of Medicine at Mount Sinai · US

Funding

Single Nephron and MetabolomicsP30DK079307 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CARATTINO, MARCELO DANIEL · 2008 to 2022
$13.4M
The role of DNA damage response in chronic kidney diseaseR01DK115403 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI AIRIK, RANNAR · 2018 to 2022
$1.5M
NIDDK NIH HHS P30 DK079307NIDDK NIH HHS R01 DK115403
6 · The paper itself

Abstract

Defective DNA repair pathways contribute to the development of chronic kidney disease (CKD) in humans. However, the molecular mechanisms underlying DNA damage-induced CKD pathogenesis are not well understood. Here, we investigated the role of tubular cell DNA damage in the pathogenesis of CKD using mice in which the DNA repair protein Fan1 was knocked out. The phenotype of these mice is orthologous to the human DNA damage syndrome, karyomegalic interstitial nephritis (KIN). Inactivation of Fan1 in kidney proximal tubule cells sensitized the kidneys to genotoxic and obstructive injury characterized by replication stress and persistent DNA damage response activity. Accumulation of DNA damage in Fan1 tubular cells induced epithelial dedifferentiation and tubular injury. Characteristic to KIN, cells with chronic DNA damage failed to complete mitosis and underwent polyploidization. In vitro and in vivo studies showed that polyploidization was caused by the overexpression of DNA replication factors CDT1 and CDC6 in FAN1 deficient cells. Mechanistically, inhibiting DNA replication with Roscovitine reduced tubular injury, blocked the development of KIN and mitigated kidney function in these Fan1 knockout mice. Thus, our data delineate a mechanistic pathway by which persistent DNA damage in the kidney tubular cells leads to kidney injury and development of CKD. Furthermore, therapeutic modulation of cell cycle activity may provide an opportunity to mitigate the DNA damage response induced CKD progression.

Indexed as

Nephritis, InterstitialRenal Insufficiency, ChronicAnimalsDNA DamageDNA RepairEndodeoxyribonucleasesExodeoxyribonucleasesFibrosisHumansKidneyMiceMice, KnockoutMultifunctional EnzymesRoscovitineEndodeoxyribonucleasesExodeoxyribonucleasesFAN1 protein, humanFan1 protein, mouseMultifunctional EnzymesRoscovitinechronic kidney diseaseDNA damageDNA re-replicationFAN1karyomegalic interstitial nephritis

Identifiers

PMID35931300
PMCPMC9588672
OpenAlexW4289526124

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.